NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
50 hedge funds and large institutions have $6.65M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 3 closing their positions.
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
12
Closed
3
Calls
$44K
Puts
$233K
Net Calls
-$189K
Net Calls Change
+$506K